Discover the most common GMP errors in Good Manufacturing Practices certification for cosmetics and the latest regulatory updates from the FDA, WHO, and Latin America. Learn how a smart solution like InstantGMP PRO can eliminate documentation and process errors.
Compliance with Good Manufacturing Practices (GMP) is not just an obligation; it’s the key to quality, safety, and efficiency. Did you know that many common errors can be resolved with a smart solution? We invite you to discover how to optimize your processes and avoid costly nonconformities.
The Latest in Regulations: Stay Updated to Lead
The regulatory landscape is constantly evolving. Staying abreast of major updates is crucial to staying competitive and ensuring the compliance of your cosmetic products.
Major Recent Updates to Consider:
- WHO Quality Compendium – 10th Edition (February 2024): With 46 guides (8 new, 10 revised) covering sterile products, investigational substances, validation, and use of pharmaceutical water.
- WHO New/Revised Guideline Package – TRS 1060 (March 2025): Includes annexes and revisions on nitrosamine control, GMP for excipients, bioanalytical methodology, and regulatory cooperation.
- US FDA Quality Management Maturity (QMM) Program for 2025: Extension of the voluntary program assessing management commitment to quality, business continuity, and advanced pharmaceutical quality systems.
- New FDA Guidance on Lot Consistency and Advanced Technologies: Focusing on 21 CFR 211.110, lot-to-lot consistency, and product integrity, especially with advanced manufacturing technologies and process models.
- PIC/S and EMA Updates to GMP Guidance: Public consultations to revise the PIC/S “Guide to GMP for Medicinal Products” (Chapter 4: Documentation, Annex 11: Computerized Systems, New Annex 22: Artificial Intelligence) and revision of Chapter 1 of the EU GMP (EudraLex, Volume 4) to strengthen QRM and Knowledge Management.
- Guidelines for WHO Reference Chemical Substances: Draft (“Working document QAS/25.972”) to update guidance.
Global changes
- WHO (TRS 1060, 2025): New guidance on nitrosamines, excipients, bioanalysis, and regulatory cooperation.
- FDA (US): Expands its Quality Management Maturity program and publishes guidance on lot consistency and advanced manufacturing.
- PIC/S and EMA: Revise chapters on documentation, computerized systems, and incorporate AI and Quality Risk Management.
- Singapore: Requires GMP evidence for drug substance manufacturers starting in October 2024.
- India: Extends the deadline for SMEs to comply with the new Schedule M until December 2025.
Changes in LATAM
México:
- New NOM-241-SSA1-2025 (GMP for medical devices) enters into force in November 2025.
- COFEPRIS accepts GMP certificates from several Latin American countries.
- NOM-059 for biotechnological medicines is under review.
Brazil:
- RDC 982/2025 creates a risk-based GMP certification system.
- Recognition of equivalent foreign inspections (reliance).
- Peru: automatic registrations if DIGEMID does not respond within 45 days.
- Colombia: reforms to streamline procedures based on risk level.
- Regional trend: greater harmonization and mutual recognition of GMP certifications.
Key Trends: Your Compass in the Regulatory Environment
Regulations not only change, but they also determine the direction in which the industry is moving. Pay attention to these points:
- Increased regulations or guidelines on digital technologies: computerized systems, artificial intelligence, data management, electronic documentation.
- Strengthened focus on quality risk management, corporate knowledge, and periodic quality reviews.
- Global harmonization: The WHO, PIC/S, EMA, FDA, and other regulators seek to align criteria, facilitating mutual recognition and reducing redundancies in inspections/exports.
- Transparency and stricter data integrity, batch consistency, process validation, etc.
- Specific regulations for reference substances, excipients, sterile products, nitrosamines, etc.
- Serious Adverse Event Reporting (MoCRA): Pay Attention to the Deadline!
The Serious Adverse Event Reporting requirement went into effect on December 29, 2023. This is part of the Modernization of Cosmetic Regulation Act of 2022 (MoCRA).
- Important Details:
- The Responsible Person must submit to the FDA any report they receive of a serious adverse event associated with the use of a cosmetic product in the United States.
- Notification to the FDA: within 15 business days of receipt.
- “New and relevant” information: must be submitted within one year of the initial report.
- Retain records of all adverse events for six years (three years for certain small businesses).
The Most Common Mistakes in GMP Certification for the Cosmetics Industry
Good Manufacturing Practices (GMP) certification, often guided by ISO 22716, is compromised by recurring flaws. These are the weaknesses consistently identified by the FDA and other regulatory bodies:
1. Errors in Good Documentation Practices (GDP):
- Missing signatures, incorrect corrections, sloppy manual documentation (data integrity gaps).
- Standard operating procedures (SOPs) that are nonexistent, inaccurate, or not followed.
- Failure to reflect changes in documents or stability validations.
- Problems with the Quality Control Unit’s procedures.
2. Installation and Design Related Failures:
- Inadequate design that does not prevent cross-contamination (in areas not separated for storage, production, and quality control).
- Poor control of environmental conditions (temperature, humidity).
3. Problems with Cleaning and Maintenance:
- Poor cleaning of equipment or facilities.
- Failure to perform the cleaning validation protocol or use of incorrect elements.
4. Process and Quality Control Errors:
- Releasing unqualified equipment.
- Poor sampling or weighing processes.
- Materials/Raw materials of variable quality or selected solely by price.
- Failures in the investigation of discrepancies.
5. Personnel Related Failures:
- Qualification failures, lack of knowledge, or inadequate staff training.
- Negligence, apathy, and resistance to change.
- The good news is that all of these errors can be resolved.
- The key is to go beyond minimum compliance, managing a comprehensive strategy.
- BPM, Quality, and Productivity: An Essential Synergy
GMP compliance is not a cost; it’s an investment. The interrelationship between GMP, quality, and productivity is symbiotic and fundamental:
1. Interrelation with Quality and Safety:
- Emphasis on Prevention: GMPs are a preventative system for anticipating and eliminating quality problems.
- Compliance Assurance: Ensures that products are consistently produced under established procedures.
- Control of Critical Factors: From ingredient selection to storage.
- Definition of Specifications and Conformity: Requirement to establish and meet specifications at each stage.
- Qualification and Consistency: Process validation ensures consistent and compliant products.
- Defect Management: Systematic approach to managing complaints, product recalls, and corrective actions..
2. Interrelation with Productivity and Efficiency:
- Standardization and Error Reduction: Defined and controlled processes that prevent failures.
- Improved Operational Management: Optimization of planning, organization, and control.
- Documentation and Efficiency (Traceability): Methodical (digital) records that enable traceability and accelerate batch release.
- Optimized Human Resources: Trained and qualified personnel to execute procedures.
- Cost Control: Accurate cost calculations, waste reduction, and operational efficiency.
- Reduced Regulatory Delays: Compliance that reduces inspection procedures and avoids costly recalls.
The Smart Solution to Your GMP Problems.
All of the compliance issues we’ve just described can be resolved with the implementation of specialized software. InstantGMP™ PRO is a comprehensive cloud-based solution that manages manufacturing, inventory, and quality, specifically designed to meet FDA and GMP regulations.P).
It’s not just about passing an audit. It’s about having the peace of mind that comes from knowing your operation is efficient, secure, and future-proof,
Said Angelo Nardone, Chief Technology Officer of InstantGMP, Inc.
How does InstantGMP™ PRO help you avoid these errors?
- Elimination of Document Errors and Data Integrity (BPD):
Electronic Batch Records (EBR/eBMR): Replaces error-prone manual record-keeping, with version control, traceability, and electronic signatures that comply with 21 CFR Part 11.
Traceability and Audit: Complete audit trail that records all actions, automatically linking MES, QMS, and ERP for complete data integrity.
Procedures and Records: Quality documentation is organized electronically, and the MES ensures that the Batch Production Record (BPR) follows the Master Production Record (MMR/MPR).
- Mitigation of Process, Sampling, and Weighing Errors:
Automated Weighing Control: Integration with scales for accurate measurement and automatic data capture, reducing mix-ups and incorrect labels.
Real-Time Inventory Control: Accurate material tracking, preventing errors due to discrepancies or shortages, with access controls.
SOP Enforcement: The MES guides operators step-by-step, requiring the recording of critical parameters and issuing instant alerts for deviations.
- Troubleshooting Staff Qualification and Training:
Learning Management System (LMS): Creates, organizes, and manages training curricula, prerequisites, and assessments, maintaining records for compliance.
Competency Verification: The MES restricts access to specific processes to qualified personnel only, preventing errors due to lack of training.
- Facility, Equipment, and Maintenance Control:
Equipment and Room Log: One-click access to usage and maintenance logs to complete and verify mandatory entries.
Maintenance Automation: The MES automates the scheduling and recording of cleaning and maintenance procedures, ensuring that equipment is not used outside its recommended service interval.
- Quality Management (CAPA and Deviations):
Comprehensive QMS Module: Helps manage specifications, accuracy, and compliance.
Integrated Deviation Management: Deviation reports are activated in the MES/EBR and flow directly to the QMS, accelerating the resolution and root cause analysis of CAPAs.
WATCH THE FULL INTERVIEW HERE
Request your personalized demo and simplify your BPM now.
Don’t risk your reputation or compromise the quality of your products. Ensure GMP compliance, optimize your operations, and unlock your growth potential with InstantGMP .
Request Your Personalized Demo and Simplify Your GMP Right Now.
